BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1927052)

  • 1. [Prevalence of psychotropic and anti-epileptic drug use in mentally handicapped students].
    Meins W
    Z Kinder Jugendpsychiatr; 1991 Mar; 19(1):15-8. PubMed ID: 1927052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with anti-epileptic drugs--a survey of mentally handicapped adults].
    Meins W
    Rehabilitation (Stuttg); 1989 Feb; 28(1):10-4. PubMed ID: 2564691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of psychotropic drugs in mentally handicapped adults].
    Meins W
    Psychiatr Prax; 1988 Nov; 15(6):218-22. PubMed ID: 3237896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative survey of drug use in a community service system.
    Zaharia ES; Struxness L
    Ment Retard; 1991 Aug; 29(4):191-4. PubMed ID: 1921727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of psychoactive drug use among North Dakota group home residents.
    Burd L; Fisher W; Vesely BN; Williams M; Kerbeshian J; Leech C
    Am J Ment Retard; 1991 Sep; 96(2):119-26. PubMed ID: 1930945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
    Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 12. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of epilepsy in a mentally retarded population: lack of correlation with IQ, neurological status, and electroencephalogram.
    Marcus JC
    Am J Ment Retard; 1993; 98 Suppl():47-51. PubMed ID: 8352922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug use by mentally handicapped persons in institutions and family-replacing residential facilities].
    van Schrojenstein Lantman-de Valk HM; Kessels AG; Haveman MJ; Maaskant MA; Urlings HF; van den Akker M
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1083-8. PubMed ID: 7783802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of psychotropic medication in childhood and adolescence in the Federal Republic of Germany.
    Elliger TJ; Trott GE; Nissen G
    Pharmacopsychiatry; 1990 Jan; 23(1):38-44. PubMed ID: 2315376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some studies in an institution for the mentally retarded.
    Sewell J; Werry JS
    N Z Med J; 1976 Oct; 84(574):317-9. PubMed ID: 14320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
    Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D
    Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.